49
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Immune responses to orally administered PLGA microparticles: influence of oil vehicles and surfactive agents

, , , &
Pages 525-536 | Received 11 Jun 2003, Accepted 11 Jun 2003, Published online: 11 Jun 2003

  • MURANISHI, S., TOKUNAGA, Y., TANIGUCHI, K. and SEZAKI, H., 1977, Potential absorption of heparin from the small and the large intestine in the presence of monoolein mixed micelles. Chemical Pharmaceutical Bulletin, 25, 1159-1161.
  • PORTER, C. J. H., CHARMAN, S. A. and CHARMAN, W. N., 1996, Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. Journal of Pharmaceutical Science, 85, 351-356.
  • CHAVES, F., CALVO, J.C., CARVAJAL, C., RIVERA, Z., RAMIREZ, L., PINTO, M., TRUJILLO, M., GUZMAN, F., PATARROYO, M. E., 2001, Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages. Journal of Peptide Research, 58, 307-316.
  • CHEEMA, M., PALIN, K. J. and DAVIS, S. S., 1987, Lipid vehicles for intestinal lymphatic drug absorption. Journal of Pharmaceutics and Pharmacology, 39, 55-56.
  • HIRAI, H., YASHIKI, T. and MIMA, H., 1981, Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. International Journal of Pharmaceutics, 9, 173-184.
  • MASUDA, Y., YOSHIKAWA, H., TAKADA, K. and MURANISHI, S., 1986, The mode of enhanced enteral absorption of macromolecules by lipid-surfactant mixed micelles. Journal of Pharmacobiodynamics, 9, 793-798.
  • MURANISHI, S., 1990, Absorption enhancers. Critical Reviews in Therapy and Drug Carrier Systems, 7, 1-33.
  • RADWAN, M. A. and ABOUL-ENEIN, H. Y., 2002, The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. Journal of Microencapsulation, 19, 225-235.
  • ROSAS, J. E., HERNÁNDEZ, R. M., GASCON, A. R., IGARTUA, M., GUZMaN, F., PATARROYO, M. E. and PEDRAZ, J. L., 2001, Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine, 19, 4445-4451.
  • SAGHIR, M., WERNER, J. and LAPOSATA, M., 1997, Rapid in vivo hydrolysis of fatty acid ethyl esthers, toxic nonoxidative ethanol metabolites. American Journal of Physiology, 273, G184-G190.
  • SAH, H. and CHIEN, Y. W., 1996, Prolonged immune response evoked by a single subcutaneous injection of microcapsules having a monophasic antigen release. Journal of Pharmaceutics and Pharmacology, 48, 32-36.
  • WATANABE, E., SUDO, R., TAKAHASHI, M. and HAYASHI, M., 2000, Evaluation of absorbability of poorly water-soluble drugs: validity of the use of additives. Biology and Pharmaceutics Bulletin, 23, 838-843.
  • ROSAS, J. E., PEDRAZ, J. L., HERNÁNDEZ, R. M., GASCON, A. R., IGARTUA, M., GUZMÁN, F., Rodriguez, R. and CORTAS, J., 2002, Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunization of SPf66 encapsulated in PLGA microspheres. Vaccine, 20, 1707-1710.
  • WITSCHI, C. and DOELKER, E., 1998, Peptide degradation during preparation and in vitro release testing of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) microparticles. International Journal of Pharmaceutics, 171, 1-18.
  • DONOVAN, M. D., FLYNN, G. L. and AMIDON, G. L., 1990, The molecular weight dependence of nasal absorption: The effect of absorption enhancers. Pharmaceutical Research, 7, 808-815.
  • FLORENCE, T., 1997, The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharmaceutical Research, 14, 259-266.
  • GORDON, G. S., MOSES, A. C., SILVERS, R. D., FLIER, J. S. and CAREY, M. C., 1985, Nasal absorption of insulin: enhancement by hydrophobic bile-salts. Proceedings of the National Academy of Sciences (USA), 82, 7419-7423.
  • CALIPH, S. M., CHARMAN, W. N. and PORTER, C. J. H., 2000, Effect of short-, medium- and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated andnon-cannulated rats. Journal of Pharmaceutical Science, 89, 1073-1084.
  • BLANCO, M. D. and ALONSO, M. J., 1997, Development and characterization of proteinloaded poly(lactide-co-glycolide) nanospheres. European Journal of Pharmaceutics and Biopharmaceutics, 43, 287-294.
  • DAMGE, C., VRANCKX, H., BALSCHMIDT, P. and COUVREUR, P., 1997, Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. Journal of Pharmaceutical Science, 86, 1403-1409.
  • DESAI, M. P., LABHASETWAR, V., AMIDON, G. L. and LEVY, R. J., 1996, Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharmaceutical Research, 13, 1838-1845.
  • DONNELLY, A., KELLAWAY, I. W., TAYLOR, G. and GIBSON, M., 1998, Absorption enhancers as tools to determine the route of nasal absorption of peptides. Journal of Drug Targeting, S, 121-127.
  • GUTIERRO, I., HERNÁNDEZ, R.M., IGARTUA, M., GASCON, A. R. and PEDRAZ, J. L., 2002, Influence of dose and immunization route on the serum IgG antibody response to BSA loaded PLGA microspheres. Vaccine, 20, 2181-2190.
  • HILLERY, A. M. and FLORENCE, A. T., 1996, The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat. International Journal of Pharmaceutics, 132, 123-130.
  • HOPKINS, S., FISHER, G., KRAEHENBUHL, J. P. and VELIN, D., 1998, Nasal-associated lymphoid tissue. A site for vaccination and pathogen entry. STP Pharmaceutical Science, 8, 47-51.
  • JONES, B. G., DICKINSON, P. A., GUMBLETON, M. and KELLAWAY, I. W., 2002, The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages. International Journal of Pharmaceutics, 236, 65-79.
  • KIBBE, A. H., 2000, Handbook of pharmaceutical excipients, 3rd edn. (Washington DC: American Pharmaceutical Association and Pharmaceutical Press), pp. 386-388.
  • IGARTUA, M., HERNÁNDEZ, R. M., ESQUISABEL, A., GASCON, A. R., CALVO, M. B. and PEDRAZ, J. L., 1997, Influence of formulation variables on the in vitro release of albumin from biodegradable microparticulate systems. Journal of Microencapsulation, 14, 349-356.
  • MORIMOTO, K., UEMARA, Y., IWANAGA, K., KAKEMI, M., OHASHI, Y., TANARA, A. and NAKAI, Y., 1998, Influence of absorption enhancers (bile salts) and the preservative (benzalkonium chloride) on mucociliary function and permeation barrier function in rabbit tracheas. European Journal of Pharmaceutical Science, 6, 225-230.
  • IGARTUA, M., HERNÁNDEZ, R. M., ESQUISABEL, A., GASCON, A. R., CALVO, M. B. and PEDRAZ, J. L., 1998, Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis. International Journal of Pharmaceutics, 169, 45-54.
  • JOSHI, M. B., GAM, A. A., BOYKINS, R. A., KUMAR, S., SACCI, J., HUFFMAN, S. L., NAKHASI, H. L. and KENNEY, R. T., 2001, Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates. Infectious Immunology, 69, 4884-4890.
  • LUNDIN, P. D. P., BOJRUP, M., LJUSBERG-WAHREN, H., WESTROM, B. R. and LUNDIN, S., 1997, Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP). Journal of Pharmacy and Experimental Therapy, 282, 585-590.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.